An interventional study of AI in Pneumonia and Lung Cancer, sponsored by Duke-NUS Graduate Medical School. Not yet recruiting. Open to participants aged 14 Years to 130 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-13.
Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Randomized Clinical Trial of the impact of Chest radiograph AI-assisted triage and report generation upon clinical outcomes and an economic analysis of impact of AI decision support on radiology service delivery.
Randomized, prospective selection of patients. Control group involves radiologists reporting chest radiographs as per reference standard clinical workflow Intervention group involves radiologists assisted with AI reporting an AI-triaged worklist of chest radiographs using an AI report generation tool Clinical outcomes on patients are studied at pre-determined study endpoints, including time to discharge from the hospital and re-admission rates.
Economic analysis on cost-avoidance from man-hours saved from report generation and triage.
1,569 studies on the registry are indexed under Pneumonia; 267 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 128 across 978 interventional studies indexed under Pneumonia.
Browse Pneumonia studies →Duke-NUS Graduate Medical School is the lead sponsor of 63 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Chest radiographs reported with AI assistance
AI assisted detection, triage and reporting of CXR
Diagnostic Test: AI
Artificial intelligence triage and reporting system
Report generation time
Time for radiologist to produce each individual CXR report
Time frame: 12 months
Turnaround Time
Time from patient arrival at radiography department to time for clinical team to receive report
Time frame: 12 months
Time to discharge
Time from patient arrival at radiography department to time to discharge from hospital
Time frame: 12 months
30-day patient readmission rate
Rate of readmission of patient to hospital after discharge within 30 days
Time frame: 12 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2024; primary completion for Sep 2025, 11 months later.
Of 260 non-industry interventional studies with no phase under Pneumonia, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 31. This study's planned 11 months is below that.
Counting every sponsor, half of 267 studies reached it within 22 months; a quarter within 11 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke-NUS Graduate Medical School